PGI Chandigarh starts Plasma therapy trial in Covid-19 positive patients
PGI Chandigarh has been chosen as one of the national centers by Indian Council of Medical Research (ICMR) to conduct trial
Chandigarh: PGI Chandigarh has been chosen as one of the national centers by Indian Council of Medical Research (ICMR) to conduct trial of convalescent plasma therapy in patients with serious Covid infection. The approval was received on last Friday.
With this approval, serious sick Covid 19 positive patients admitted in Nehru Hospital Extension Block will be eligible to get this form of treatment.
The collaborative departments for this trial are Depts of Internal Medicine, Anaesthesia and Intensive Care, Transfusion Medicine, Endocrinology, Virology and community Medicine.
The study is aimed at assessing the safety and efficacy of convalescent plasma to limit complications in Covid-19 patients.